CardioNet Inc.

Dr. Prystowsky has been a member of our board of directors since March 2001. Since 1988, Dr. Prystowsky has served as the Director, Clinical Electrophysiology Laboratory at St. Vincent Hospital, Indianapolis Indiana. Since 1988, Dr. Prystowsky has served as Consulting Professor of Medicine at Duke University. Since 2004, he has served as the associate editor of Hurst Textbook of Cardiology and, since January 2004, he has served as editor-in-chief of the Journal of Cardiovascular Electrophysiology. From 1992 to 1994, he served as the Chairman of the American Heart Association’s Committee on Electrocardiography and Electrophysiology and, from May 2001 to May 2002, as President of the Heart Rhythm Society. Dr. Prystowsky currently serves as the Chairman of the ABIM test writing committee for the Electrophysiology Boards. Dr. Prystowsky currently serves on the board of directors of Stereotaxis, Inc., a biotechnology company. Dr. Prystowsky received an undergraduate degree from the Pennsylvania State University and an M.D. from the Mount Sinai School of Medicine.

Martin P. Galvan joined CardioNet in October 2007. Previously, Marty held several positions with Viasys Healthcare Inc., a healthcare technology company, most recently as Executive Vice President, Chief Financial Officer and Director Investor Relations. From 1999 to 2001, he served as Chief Financial Officer of Rodel, Inc., a precision surface technologies company. From 1979 to 1998, Marty held several positions with Rhone-Poulenc Rorer Pharmaceuticals, Inc., including Vice President Finance Worldwide; President & General Manager, RPR Mexico & Central America; Vice President, Finance, Europe/Asia Pacific; and Chief Financial Officer, United Kingdom and Ireland. Marty received an undergraduate degree in Economics from Rutgers University.

Dr. Kowey joined CardioNet as its Medical Director in 2002 and was named Chairman of the MAB in March, 2009. He is Chief of the Division of Cardiovascular Diseases for the Main Line Health System, including Lankenau Hospital. He is also Professor of Medicine and Clinical Pharmacology at Jefferson Medical College, and President of the Heart Center of the Main Line Health System. He has served as a member of the Cardiorenal Drug Advisory Committee and the Cardiovascular Devices Committee of the U.S. Food and Drug Administration and holds the William Wikoff Smith Chair in Cardiovascular Research. Dr. Kowey received his medical degree from the University of Pennsylvania School of Medicine.

Anna McNamara joined CardioNet from LifeWatch, where she served as Executive Vice President of Clinical Operations, responsible for all clinical monitoring operations, clinical research activities, and quality assurance. Prior to that experience, Anna served as Vice President of Clinical Operations for Quality Diagnostic Services/WebMD, and led clinical operations at NMC Diagnostic Services and Survival Technology Inc. Previously, Anna served as RN team leader in cardiac care units at New York University Hospital and Bellevue Hospital. Anna received her B.A. from Marymount College in New York City and her RN at Mercy Hospital in Scranton, PA.

Edward Stone, a 25 year veteran of healthcare reimbursement, regulatory and compliance operations has performed in various arenas including regional HME providers, small orthopedic technology start-up businesses, large national home care and infusion providers, and mid-size diagnostic service providers. His experiences range from operational strategic planning, compliant sales-growth & managed care strategies, HIPAA, and reimbursement-billing operations.

JR Finkelmeier has served as the Vice President of Marketing since May 2007. JR joined CardioNet following the acquisition of PDSHeart, where he served as Regional Sales Director from December 2005 to May 2007 and as Regional Accounts Manager from March 2003 to November 2005. From 2000 to February 2003, JR served as General Manager of Veritas Partners, a Midwest-based venture capital and management company. JR received an undergraduate degree in Pre-Professional Studies from the University of Notre Dame.

Mike Forese joined CardioNet from CRT Pharmaceuticals where he served as Chief Operating and Chief Financial Officer. He previously served in senior financial and operating roles in companies such as Research Pharmaceutical Services, Inc, IBAH Pharmaceutical Services, Paraxel International and Imperial Chemical Industries. Mike received his undergraduate degree in Accounting from Villanova University and an MBA from Drexel University.

Philip joined CardioNet with over 16 years of experience working with CMS, commercial payors, managed care organizations and reimbursement services. Prior to joining CardioNet, Philip successfully served in numerous sales and executive sales management positions within Legend Healthcare where he was one of their initial hires and concluded as Executive Vice President/COO. Philip has negotiated hundreds of contracts, including fee for service and risk sharing arrangements as well. Philip received his undergraduate degree from Western New England College in Springfield MA and was a Board Member of CHAP (Community Health Accreditation Program) from April 2000 – April 2001.

Harry T. Rein is a General Partner with Foundation Medical Partners. Mr. Rein served for 15 years as the Founder and Managing General Partner of Canaan Partners. In addition to his role as the Managing General Partner at Canaan Partners, Mr. Rein was responsible for Canaan's Life Sciences Investment Practice. Mr. Rein has extensive experience with small and mid-sized companies, including the supervision of all investments made by GE Venture Capital during his tenure as President. Mr. Rein has served on the boards of directors of over 20 public and private entrepreneurial companies. Mr. Rein also serves as a Trustee of The Cleveland Clinic Foundation, and is a member of the Clinic's Executive, Strategic Planning, Research and Education, and Finance and Budgeting committees. Mr. Rein attended Emory University and Oglethorpe College (1968) and holds an M.B.A. from the Darden School at the University of Virginia (1973).

Dr. Benditt is Professor of Medicine and Co-Director of the Cardiac Arrhythmia and Syncope Center at University of Minnesota Medical School. Dr. Benditt is a past president of the North American Society for Pacing and Electrophysiology (now known as the Heart Rhythm Society). He currently is an Associate editor with the Journal of Interventional Electrophysiology (JICE) and is an editorial board member of the Journal of the American College of Cardiology (JACC), Europace, and the American Journal of Cardiology (AJC). Dr. Benditt received his medical degree from the University of Manitoba.

Dr. Rubin has been a member of our board of directors since July 2007. He has been a clinical professor of medicine at Georgetown University since 1995. From 1987 to 2001, he was president of the Lewin Group (purchased by Quintiles Transnational Corp. in 1996), a national health policy and management consulting firm. From 1994 to 1996, Dr. Rubin served as Medical Director of ValueRx, a pharmaceutical benefits company. From 1992 to 1996, Dr. Rubin served as President of Lewin-VHI, a health care consulting company. From 1987 to 1992, he served as President of Lewin-ICF, a health care consulting company. From 1984 to 1987, Dr. Rubin served as a principal for ICF, Inc., a health care consulting company. From 1981 to 1984, Dr. Rubin served as the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services and as an Assistant Surgeon General in the United States Public Health Service. Dr. Rubin is a board certified nephrologist and internist. Dr. Rubin received an undergraduate degree in political science from Williams College and an M.D. from Cornell University.